Knowledge Content
#### 1. Basal Frequency: The Classic Logic of Once-Weekly Dosing
Its half-life is approximately 8-10 days. After a single injection of 200-300 mg, blood concentrations peak within 48-72 hours (approximately 800-1200 ng/dL), then slowly decline, remaining within the therapeutic window (500-700 ng/dL) after 7 days. Weekly injections at a fixed time (such as Mondays) can reduce concentration fluctuations and are particularly suitable for patients with hypogonadism. After 8 weeks of continuous dosing, indicators such as libido and muscle strength improve by over 70%, and the incidence of side effects such as water and sodium retention is lower than with a twice-weekly regimen.https://www.fiercerawsource.com/steroid-finished/steroid-finished-oils/stromusc-brand-250mg-ml-testosterone.html
#### 2. Advanced Adjustments: Precise Optimization of Weekly Injections
For fitness enthusiasts or those who require higher testosterone peaks, a "twice-weekly" regimen (e.g., Monday/Thursday) can be adopted. This splits the weekly dose into two or three equal parts, resulting in a more gradual peak in blood concentrations (avoiding acne-causing effects from a single dose) while also shortening the trough period (concentrations over seven days are 15%-20% higher than once-weekly). Experiments have shown that this regimen can increase muscle protein synthesis by 10% and reduce luteinizing hormone (LH) suppression by 8%, further protecting gonadal axis function.
#### 3. Frequency Adaptation for Special Scenarios
- Low-dose maintenance (e.g., late TRT): Administer once every 10-14 days (100-150mg), leveraging its long-lasting effect to reduce the frequency of injections while avoiding excessive increases in testosterone levels.
- Competition Prep: Switch to twice-weekly for six weeks before competition (total dose remains the same) to stabilize concentrations and reduce the risk of estrogen conversion (because frequent injections reduce the single dose, thereby reducing aromatase substrate).
The essence of dosing frequency is "achieving target concentration with minimal fluctuation" and needs to be dynamically adjusted based on blood drug test results. When the trough concentration is lower than 300 ng/dL, the cycle is shortened, and when it is higher than 1000 ng/dL, the interval is extended. This is the core logic of balancing efficacy and safety.
